PNC FINANCIAL SERVICES GROUP, INC.

Position in DSGN — Design Therapeutics, Inc.

CIK 713676 Pittsburgh, PA

Position in DSGN

as of Mar 31, 2026 · filed May 8, 2026 Compact

Position Value

$19,322

+$2,290 QoQ

Shares Held

1,816

0.0% QoQ

Ownership

0.003%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Dec 2023

10 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Mar 31, 2026

PNC FINANCIAL SERVICES GROUP, INC. holds $99,747,802 across 265 Biotechnology names. DSGN ranks #112 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	71,942	$32,124,978
2	REGN	Regeneron Pharmaceuticals, Inc.	18,226	$14,082,131
3	TECH	BIO-TECHNE Corp	93,722	$4,897,909
4	ALNY	Alnylam Pharmaceuticals, Inc.	12,322	$4,076,976
5	MRNA	Moderna, Inc.	69,883	$3,550,054
6	INCY	Incyte Corp	33,976	$3,197,817
7	DNTH	Dianthus Therapeutics, Inc. /DE/	37,360	$3,135,250
8	ARGX	Argenx SE	3,796	$2,772,027

10 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$19,322	1,816	0.0%	Shares	Defined	2026-05-08
2025-12-31	$17,032	1,816	-0.4%	Shares	Defined	2026-02-06
2025-09-30	$13,726	1,823	+9.1%	Shares	Defined	2025-11-07
2025-06-30	$5,631	1,671	-81.9%	Shares	Defined	2025-08-08
2025-03-31	$35,708	9,251	+0.3%	Shares	Defined	2025-05-09
2024-12-31	$56,881	9,219	0.0%	Shares	Defined	2025-02-07
2024-09-30	$49,598	9,219	-4.9%	Shares	Defined	2024-11-08
2024-06-30	$32,468	9,692	-10.6%	Shares	Defined	2024-08-09
2024-03-31	$43,697	10,843	+636.1%	Shares	Defined	2024-05-10
2023-12-31	$3,903	1,473	—	Shares	Defined	2024-03-22
No filing history on record for this holder in this stock.